Concepedia

Andrea Forschner

AF

Statistics

Publications

91

Citations

4.6K

H-Index

32

Active since

2003

Affiliations

University of Tübingen(Current)

Heidelberg University

German Cancer Research Center

University Hospital Heidelberg

University Children's Hospital Tübingen

Andrea Forschner is an author at University of Tübingen specializing in oncology, medicine, and immunotherapy.

ORCID

Publications per year

2003–2024

91

Publications

91

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

Lars Hofmann, Andrea Forschner, Carmen Loquai et al. · European Journal of Cancer · 2016 · 647 citations

, , +14

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

Lisa Zimmer, Simone M. Goldinger, Lars Hofmann et al. · European Journal of Cancer · 2016 · 560 citations

, , +11

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study

Andrea Forschner, Florian Battke, Dirk Hadaschik et al. · Journal for ImmunoTherapy of Cancer · 2019 · 211 citations · Full text

, , +17

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

Markus V. Heppt, Lucie Heinzerling, Katharina C. Kähler et al. · European Journal of Cancer · 2017 · 203 citations

, , +17

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

Lisa Zimmer, Susmitha Apuri, Zeynep Eroglu et al. · European Journal of Cancer · 2017 · 188 citations

, , +14

1–5 of 91